Interleukin-2 fusion proteins and uses thereof
US11365232B2 · kind B2 · utility
1Cited by
7References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 2020 |
| Grant date | Jun 21, 2022 |
| Priority date | — |
| Expiry date | Feb 5, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to fusion proteins of immunoglobulins and interleukin-2 (IL-2). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.